For the study, researchers used two hospital billing databases for inpatient discharges from across the U.S. They included children from ages 1 to 17 admitted to the hospital for pneumonia between Jan. 1, 2009, and Sept. 30, 2015. Researchers also looked for patients discharged from children’s hospitals and non-children’s hospitals.
Researchers found 120,238 children with pneumonia were discharged from 51 children’s hospitals and 65,209 were discharged from 471 non-children’s hospitals. Four years after the national pediatric pneumonia guidelines were published, only 27 percent of children admitted to non-children’s hospitals received therapy according to national guidelines, compared to the 61 percent who received guideline-compliant treatment in children’s hospitals. National guidelines recommend penicillin, amoxicillin and ampicillin as first-line treatments for children hospitalized with pneumonia.
More articles on clinical leadership and infection control:
Olympus settles federal scope investigation for $85M
VA hospitals outperform peers in care quality, study finds
STD rates rising among senior patients: 7 things to know
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
